<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2022-4743</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-4743</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Резерв коронарного кровотока у пациентов с хронической сердечной недостаточностью с сохраненной фракцией выброса левого желудочка</article-title><trans-title-group xml:lang="en"><trans-title>Coronary flow reserve in patients with heart failure with preserved ejection fraction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0883-466X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мочула</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mochula</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., c.н.с. лаборатории радионуклидных методов исследования</p><p>Томск</p></bio><email xlink:type="simple">mochula.andrew@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2285-6438</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Копьева</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kop’eva</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., н.с. отделения патологии миокарда</p><p>Томск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1311-0378</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мальцева</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Maltseva</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант лаборатории радионуклидных методов исследования</p><p>Томск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4019-3735</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гракова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Grakova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., в.н.с. отделения патологии миокарда</p><p>Томск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5689-9754</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуля</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Gulya</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., врач-рентгенолог лаборатории радионуклидных методов исследования</p><p>Томск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3147-3025</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гусакова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Gusakova</surname><given-names>А. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.ф.н., н.с. отделения клинической лабораторной диагностики</p><p>Томск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1513-8614</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Завадовский</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zavadovsky</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., зав. лабораторией радионуклидных методов исследования</p><p>Томск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>11</day><month>03</month><year>2022</year></pub-date><volume>27</volume><issue>2</issue><fpage>4743</fpage><lpage>4743</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мочула А.В., Копьева К.В., Мальцева А.Н., Гракова Е.В., Гуля М.О., Гусакова А.М., Завадовский К.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Мочула А.В., Копьева К.В., Мальцева А.Н., Гракова Е.В., Гуля М.О., Гусакова А.М., Завадовский К.В.</copyright-holder><copyright-holder xml:lang="en">Mochula A.V., Kop’eva K.V., Maltseva A.N., Grakova E.V., Gulya M.O., Gusakova А.M., Zavadovsky K.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/4743">https://russjcardiol.elpub.ru/jour/article/view/4743</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить параметры миокардиального кровотока (МК) и резерва коронарного кровотока (РКК) у больных хронической сердечной недостаточностью (ХСН) с сохраненной фракцией выброса (ФВ) левого желудочка (ЛЖ) и оценить их взаимосвязь с тяжестью течения ХСН.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включено 47 пациентов (68,7% мужчин) в возрасте 65,0 (58,0; 72,0) лет с ФВ ЛЖ — 62 (56; 67)% и стенозом коронарных артерий &lt;50%. Оценку сывороточных уровней N-терминального фрагмента промозгового натрийуретического пептида (NT-proBNP) выполняли с помощью иммуноферментного анализа исходно. Величины МК и РКК оценивали с помощью динамической однофотонной эмиссионной компьютерной томографии миокарда.</p></sec><sec><title>Результаты</title><p>Результаты. В зависимости от уровней NT-proBNP больные были разделены на 2 группы (р&lt;0,001): в 1 группу вошли (n=15) пациенты с уровнями NTproBNP &lt;125 пг/мл (58,2 (41,6; 70,7) пг/мл), во 2 (n=32) — с гиперэкспрессией NT-proBNP ≥125 пг/мл (511,4 (249,8; 1578,1) пг/мл). Группа больных с гиперэкспрессией NT-proBNP характеризовалась более высокими значениями (на 33,8%, р=0,0001) МК в условиях функционального покоя и сниженной величиной РКК (на 14,7%, p=0,001) по сравнению с пациентами без повышения уровня данного биохимического показателя: МК в покое — 0,65 (0,44; 0,79) vs 0,43 (0,30; 0,58) мл/мин/г; РКК — 2,21 (1,52; 2,83) vs 2,59 (2,47; 3,05), соответственно. При этом стресс-индуцированный МК не различался между группами. Установлена взаимосвязь уровней NT-proBNP c глобальным РКК (p=0,012; r=-0,339) и МК в условиях покоя (p=0,012; r=0,322). Выявлен ступенчатый характер снижения величины глобального РКК в зависимости от функционального класса (ФК) по NYHA (p&lt;0,001): 2,79 (2,52; 2,93); 1,8 (1,55; 2,08); 1,31 (1,23; 1,49) — для ФК I; ФК II; ФК III, соответственно.</p></sec><sec><title>Заключение</title><p>Заключение. Снижение РКК у пациентов с ХСН с сохраненной ФВ ЛЖ свидетельствует о нарушении кровоснабжения миокарда, которое в данной группе больных связано с изменениями, происходящими на микроциркуляторном уровне. При этом степень выраженности изменений МК в условиях покоя и коронарного резерва тесно взаимосвязаны с тяжестью течения ХСН.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the parameters of myocardial blood flow (MBF) and coronary flow reserve (CFR) in patients with heart failure (HF) with preserved ejection fraction and evaluate their relationship with the severity of HF.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 47 patients (men, 68,7%) aged 65,0 (58,0; 72,0) years with left ventricular ejection fraction of 62 (56; 67)% and coronary artery stenosis &lt;50%. Serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) were assessed by enzyme immunoassay. MBF and CFR values were assessed using cardiac single photon emission computed tomography.</p></sec><sec><title>Results</title><p>Results. Depending on NT-proBNP levels, the patients were divided into 2 groups (p&lt;0,001): the 1st group included (n=15) patients with NT-proBNP &lt;125 pg/ml (58,2 [41,6; 70,7] pg/ml), while in the 2nd group (n=32) — with NT-proBNP ≥125 pg/ml (511,4 [249,8; 1578,1] pg/ml). The group of patients with high NTproBNP levels was characterized by higher values (by 33,8%, p=0,0001) of resting MBF and reduced CFR (by 14,7%, p=0,001) compared with patients with normal NT-proBNP level: resting MBF — 0,65 (0,44; 0,79) vs 0,43 (0,30; 0,58) ml/min/g; CFR — 2,21 (1,52; 2,83) vs 2,59 (2,47; 3,05), respectively. At the same time, MBF at stress did not differ between the groups. The relationship of NTproBNP levels with global CFR (p=0,012; r=-0,339) and MBF at rest (p=0,012; r=0,322) was established. A stepwise decrease in global CFR was revealed depending on the NYHA class as follows (p&lt;0,001): 2,79 (2,52; 2,93); 1,8 (1,55; 2,08); 1,31 (1,23; 1,49) — for class I, II, and III, respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. A decrease in CFR in patients with HF with preserved ejection fraction indicates impaired myocardial blood supply, which, in this group of patients, is associated with microcirculatory changes. At the same time, the severity of MBF alterations is closely related to HF severity.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая сердечная недостаточность</kwd><kwd>сохраненная фракция выброса</kwd><kwd>натрийуретический пептид</kwd><kwd>резерв коронарного кровотока</kwd><kwd>миокардиальный кровоток</kwd><kwd>необструктивное поражение коронарных артерий</kwd></kwd-group><kwd-group xml:lang="en"><kwd>heart failure</kwd><kwd>preserved ejection fraction</kwd><kwd>natriuretic peptide</kwd><kwd>coronary flow reserve</kwd><kwd>myocardial blood flow</kwd><kwd>non-obstructive coronary artery disease</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование уровня NT-proBNP было выполнено за счет средств гранта МК-1347.2020.7; инструментальные методы исследования (ЭхоКГ, радиоизотопные исследования) — за счет темы ФНИ № AAAA-A20-120091890022-8</funding-statement><funding-statement xml:lang="en">The study of NT-proBNP level was carried out at the expense of grant MK-1347.2020.7; echocardiography and radioisotope investigations — fundamental research topic № AAAA-A20-120091890022-8</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Coma-Canellaa I, García-Vellosob M-J, Macíasa A, et al. Impaired Coronary Flow Reserve in Patients With Non-Ischemic Heart Failure. Rev Esp Cardiol. 2003;56(4):354-60. doi:10.1016/s0300-8932(03)76878-x.</mixed-citation><mixed-citation xml:lang="en">Coma-Canellaa I, García-Vellosob M-J, Macíasa A, et al. Impaired Coronary Flow Reserve in Patients With Non-Ischemic Heart Failure. Rev Esp Cardiol. 2003;56(4):354-60. doi:10.1016/s0300-8932(03)76878-x.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Копьева К.В., Тепляков А.Т., Гракова Е.В. и др. Роль нового биомаркера ST2 в оценке ремоделирования миокарда у больных хронической сердечной недостаточностью ишемического генеза с сохраненной фракцией выброса левого желудочка. Кардиология. 2018;58(S10):3343. doi:10.18087/cardio.2498.</mixed-citation><mixed-citation xml:lang="en">Kop’eva KV, Teplyakov AT, Grakova EV, et al. Role of ST2 biomarker for the evaluation of myocardial remodeling in patients with ischemic heart failure with preserved ejection fraction. Kardiologiia. 2018;58(S10):33-43. (In Russ.) doi:10.18087/cardio.2498.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rodríguez-Capitán J, Sánchez-Pérez A, Ballesteros-Pradas S, et al. Prognostic Implication of Non-Obstructive Coronary Lesions: A New Classification in Different Settings. J. Clin. Med. 2021;25;10(9):1863. doi:10.3390/jcm10091863.</mixed-citation><mixed-citation xml:lang="en">Rodríguez-Capitán J, Sánchez-Pérez A, Ballesteros-Pradas S, et al. Prognostic Implication of Non-Obstructive Coronary Lesions: A New Classification in Different Settings. J. Clin. Med. 2021;25;10(9):1863. doi:10.3390/jcm10091863.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518-27. doi:10.1161/CIRCULATIONAHA.113.008507.</mixed-citation><mixed-citation xml:lang="en">Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518-27. doi:10.1161/CIRCULATIONAHA.113.008507.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Driessen RS, Raijmakers PG, Stuijfzand WJ, et al. Myocardial perfusion imaging with PET. Int J Cardiovasc Imaging. 2017;33:1021-31. doi:10.1007/s10554-017-1084-4.</mixed-citation><mixed-citation xml:lang="en">Driessen RS, Raijmakers PG, Stuijfzand WJ, et al. Myocardial perfusion imaging with PET. Int J Cardiovasc Imaging. 2017;33:1021-31. doi:10.1007/s10554-017-1084-4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mochula A, Zavadovsky K, Andreev S, et al. Dynamic single-photon emission computed tomography data analysis: capabilities for determining functional significance of coronary artery atherosclerosis. MATEC Web of Conferences. 2016;79:01080. doi:10.1051/matecconf/20167901080.</mixed-citation><mixed-citation xml:lang="en">Mochula A, Zavadovsky K, Andreev S, et al. Dynamic single-photon emission computed tomography data analysis: capabilities for determining functional significance of coronary artery atherosclerosis. MATEC Web of Conferences. 2016;79:01080. doi:10.1051/matecconf/20167901080.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zavadovsky KV, Mochula AV, Boshchenko AA, et al. Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: Correlation and accuracy. J Nucl Cardiol. 2021;28(1):249-59. doi:10.1007/s12350-019-01678-z.</mixed-citation><mixed-citation xml:lang="en">Zavadovsky KV, Mochula AV, Boshchenko AA, et al. Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: Correlation and accuracy. J Nucl Cardiol. 2021;28(1):249-59. doi:10.1007/s12350-019-01678-z.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Agostini D, Roule V, Nganoa C, et al. First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging. 2018;45(7):1079-90. doi:10.1007/s00259-018-3958.</mixed-citation><mixed-citation xml:lang="en">Agostini D, Roule V, Nganoa C, et al. First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging. 2018;45(7):1079-90. doi:10.1007/s00259-018-3958.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129-200. doi:10.1093/eurheartj/ehw128.</mixed-citation><mixed-citation xml:lang="en">Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129-200. doi:10.1093/eurheartj/ehw128.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Мочула А.В., Мальцева А. Н., Шипулин В.В. и др. Оценка миокардиального кровотока и резерва — физиологические основы и клиническое значение перфузионной сцинтиграфии в обследовании пациентов с хроническим коронарным синдромом. Российский кардиологический журнал. 2020;25(2):3649. doi:10.15829/1560-40712020-2-3649.</mixed-citation><mixed-citation xml:lang="en">Mochula AV, Maltseva AN, Shipulin VV, et al. Evaluation of myocardial blood flow and coronary flow reserve — the physiological foundation and clinical significance of myocardial perfusion scintigraphy in the examination of patients with chronic coronary syndrome. Russian Journal of Cardiology. 2020;25(2):3649. (In Russ.) doi:10.15829/1560-40712020-2-3649.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Гракова Е.В., Копьева К.В., Тепляков А. и др. Взаимосвязь тяжести поражения коронарных артерий и экспрессии ST2 у больных с сердечной недостаточностью. Русский медицинский журнал. Медицинское обозрение. 2020;4(7):399-405. doi:10.32364/2587-6821-2020-4-7-399-405.</mixed-citation><mixed-citation xml:lang="en">Grakova EV, Kopieva KV, Teplyakov AT, et al. Association between the severity of coronary artery disease and ST expression in patients with heart failure. Russian Medical Inquiry. 2020;4(7):399-405. (In Russ.) doi:10.32364/2587-6821-2020-4-7-399-405.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shah SJ, Lam CSP, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439-50. doi:10.1093/eurheartj/ehy531.</mixed-citation><mixed-citation xml:lang="en">Shah SJ, Lam CSP, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439-50. doi:10.1093/eurheartj/ehy531.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Manfrini O, Bugiardini R, Canty J, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’. Cardiovasc Res. 2020;116(4):741-55. doi:10.1093/cvr/cvaa003.</mixed-citation><mixed-citation xml:lang="en">Manfrini O, Bugiardini R, Canty J, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’. Cardiovasc Res. 2020;116(4):741-55. doi:10.1093/cvr/cvaa003.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kato S, Saito N, Kirigaya H, et al. Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2016;5(2):e002649. doi:10.1161/JAHA.115.002649.</mixed-citation><mixed-citation xml:lang="en">Kato S, Saito N, Kirigaya H, et al. Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2016;5(2):e002649. doi:10.1161/JAHA.115.002649.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Camm JA, Luscher TF, Serruys PW. The ESC textbook of cardiovascular medicine. 2nd ed. Oxford: Oxford University Press, 2009:1398. ISBN 9780199566990.</mixed-citation><mixed-citation xml:lang="en">Camm JA, Luscher TF, Serruys PW. The ESC textbook of cardiovascular medicine. 2nd ed. Oxford: Oxford University Press, 2009:1398. ISBN 9780199566990.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Westermann D, Lindner D, Kasner M, et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2011;4(1):44-52. doi:10.1161/CIRCHEARTFAILURE.109.931451.</mixed-citation><mixed-citation xml:lang="en">Westermann D, Lindner D, Kasner M, et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2011;4(1):44-52. doi:10.1161/CIRCHEARTFAILURE.109.931451.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
